Claim Missing Document
Check
Articles

Found 3 Documents
Search

Neovaskularisasi Koroid Miopia -, Elvira; Wijaya, Victor Nugroho
Cermin Dunia Kedokteran Vol 43, No 10 (2016): Anti-aging
Publisher : PT. Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (385.322 KB) | DOI: 10.55175/cdk.v43i10.874

Abstract

Neovaskularisasi Koroid (NVK) merupakan salah satu komplikasi miopia dan miopia maligna yang mengancam penglihatan. Risiko NVK meningkat seiring dengan peningkatan angka kejadian miopia. Sampai saat ini belum ada definisi standar NVK pada miopia atau miopia maligna. Pasien NVKm dapat mengeluh gangguan visus, metamorfopsia dan skotoma. Fluorescein angiography dan optical tomography dapat digunakan untuk diagnosis NVKm. Tatalaksana NVKm terus berkembang, anti-VEGF memperbaiki, mengendalikan penyakit dan diharapkan dapat memperbaiki tajam penglihatan.Choroid neovascularization (CNV) is a vision-threatening complication of myopia and malignant myopia. CNV risk is increased along with the increased myopia prevalence. There is no standard definition of CNV in myopia or in malignant myopia. Patient with mCNV may complaint visual disturbances, metamorphopsia, and scotoma. Fluorescein angiography and optical tomography examination may aid mCNV diagnosis. Anti-VEGF may control the disease and expected to correct visual acuity.
Penyakit Mata Kering -, Elvira; Wijaya, Victor Nugroho
Cermin Dunia Kedokteran Vol 45, No 3 (2018): Muskuloskeletal
Publisher : PT. Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (340.095 KB) | DOI: 10.55175/cdk.v45i3.189

Abstract

Penyakit mata kering (PMK) adalah penyakit multifaktorial air mata dan permukaan mata dengan gejala tidak nyaman, gangguan penglihatan dan ketidakstabilan tear film yang berpotensi merusak permukaan mata. Sekitar 5%-34% penduduk di dunia menderita mata kering, angka kejadiannya meningkat seiring usia. Penyakit mata kering diklasifikasikan berdasarkan etiopatologinya, yaitu mata kering defisiensi aqueous (MKDA) dan mata kering evaporasi (MKE). Gejala mata kering dapat mempengaruhi aktivitas dan menurunkan kualitas hidup, meningkatkan gejala depresi, dan gangguan mood. Terapi terbatas mengurangi gejala.
A Case Report of a 70-Year-Old Male with Chronic Thromboembolic Pulmonary Hypertension (CTEPH), when to be aware? Chaifung Carolline; Siahaan, Sylvia Sagita; Widysanto, Allen; Wahyuni, Titis Dewi; Wijaya, Victor Nugroho; Sirait, Magdalena; Pradono, Clarissa Moira
Malang Respiratory Journal Vol. 8 No. 1 (2026): Volume 8 No 1, March 2026 Edition
Publisher : Universitaas Brawijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.mrj.2026.008.01.06

Abstract

Background Chronic thromboembolic pulmonary hypertension (CTEPH) is an uncommon disorder that arises as a complication of unresolved pulmonary embolism (PE). Without timely intervention, it poses a substantial risk of increased morbidity and mortality. Case A 70-year-old male was admitted with complaints of shortness of breath and productive cough that had persisted for three days prior to hospitalization. He reported progressive exertional dyspnea over the past six months. On examination, the patient exhibited refractory hypoxemia and jugular venous distention. Diagnostic imaging, including computed tomography pulmonary angiography (CTPA) and a lung perfusion scan, confirmed a diagnosis of CTEPH. Laboratory results revealed an elevated D-dimer level of 18.27 mg/dL. The patient was treated with subcutaneous anticoagulants and oral anticoagulant therapy, resulting in clinical improvement. Upon discharge, he was prescribed pulmonary vasodilators and lifelong anticoagulation therapy to maintain his condition. Conclusion Pulmonary vascular disease should be considered as a differential diagnosis in patients with unexplained dyspnea. CTPA is recommended as a diagnostic modality for confirming CTEPH. Lifelong anticoagulation is essential in managing CTEPH, with the primary treatment goals being the restoration of normal pulmonary blood flow, reducing the workload on the right ventricle, and preventing or addressing small vessel disease. Keywords chronic thromboembolic pulmonary hypertension, oral anticoagulant, Computed Tomography Pulmonary Angiography